Aim 1: Create new irofulven analogs for DNA-protein cross-linking. This aim focuses on design, synthesis and cytotoxicity studies of new irofulven-pharmacophore-based agents bearing an additional subunit for covalent or non-covalent trapping of TCR-asso
|Effective start/end date||7/28/10 → 7/27/13|
- SUSAN G. KOMEN FOR THE CURE
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.